Volex (AIM: VLX) upgrades FY2026 revenue to at least $1.22bn as AI data centre demand doubles and board eyes Main Market move
Can inhaled nintedanib improve tolerability and adherence in IPF treatment, according to Avalyn Pharma Inc.?
Read More 4 minute read General business news Jaykay Enterprises delivers robust Q3 growth, strengthens digital transformation with JK Technosoft acquisition Jaykay Enterprises Limited has reported remarkable financial results for the third quarter of the fiscal year 2024-25, reflecting… byPallavi MadhirajuFebruary 12, 2025